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Before the transition from intra-uterine to the extra-uterine environment,
metabolic substrates are continuously supplied via the umbilical cord. After birth the
infant after a couple of hours is supplied with enteral feeding. Until sufficient enteral
feeding is taken, the newborn infant is in a catabolic state. In catabolic conditions, the
endogenous energry stores, e.g. glycogen and fat, are used to meet the ongoing
metabolic demands. Glucose is the most important substrate. It is the major substrate
for the brain. Ketone bodies, and also possibly laclate, can be used as a substrate for
the brain, however to what extend these substrates play a role in the perinatal period
is unknown.
In the studies reported in this thesis, glucose kinetics were measured in
newborn infants. For ethical reasons, only infants were studied who received glucose
intravenously to ensure normal blood glucose concentrations. These infants were
considered to be at risk to have an imbalance between glucose production and glucose
consumption. The amount of glucose which was infused, was kept low. This dose was
chosen to prevent a total suppression of glucose production, which may occur at
higher rates. Glucose kinetics were studied with a stable isotope dilution technique.
As tracer for the glucose turnover studies, f6,6 zHz] glucose was used, allowing
calculation of the so-called, "true" endogenous glucose production, due to the fact that
there is no recycling of the tracer.
The results of our studies in small-for-gestational-age (SGA) infants (chapter
4) show, the preterm SGA infants have a significant lower GPR compared to the near
term SGA infants (1.0 r 0.7 vs. 2.3 r 0.5 mg,&g.min respectively). From this study we
conclude that preterm SGA infants are at highest risk to an imbalance in glucose
homeostasis. Beside, the lower GPR's we find in these infants, the energy stores in
the preterm SGA infants will be reduced because of a combination of shorter
gestation, and the intra-uterine growth retardation, implying that in these infants
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probably lipolysis and ketogenesis also will be reduced. The fact that GPR is higher in
SGA infants with a higher gestational age, indicates an ongoing maturation of
glycogenesis (thus both glycogenolysis and gluconeogenesis), even in case of intra-
uterine growth retardation.
Infants of diabetic mothers have since long been recognized to be at risk for
derangements of glucose metabolism in the neonatal period (1). In infants of diabetic
mother, it is hypothesized that there is a relationship between maternal diabetes and
fetal/neonatal morbidity, the so-called Pedersen hypothesis (2). This hypothesis refers
to the sequence of high maternal blood glucose concentrations leading to fetal
hyperinsulinism and subsequent fetal macrosomia. On the basis of the Pedersen
hypothesis, it should be expected that shortly after birth infants of diabetic mothers
have a low GPR and a high glucose disappearance rate, because insulin suppresses
GPR and increases glucose disappearance from the pool. Our studies in infants of
diabetic mothers (chapter 5), where the insulin-dependent diabetes ntellitus had been
tightly controlled during pregnancy, indicate that, in case of strict control of the
diabetes, the perinatal metabolism seems to be qualitatively normal. While receiving
a glucose infusion at a rate of 3.4 mg&g.min (mean), the infants had a GPR of 1.8 r
1.3 mg,&g.min (mean t SD). In the infants we studied, neither GPR was reduced
directly after birth, nor was the glucose disappearance increased. With regards to the
GPR we actually fbund the opposite, shortly after birth the infants had the highest
GPR, which decreased subsequently within a few hours. There was no relationship
between GPR and infusion rate. The higher GPRs in the first postnatal hours
probably is related to stimulus of GPR by glucagon and/or catecholamines which
increase after birth, whereas at later postnatal age due to the glucose infusion this
stimulus is reduced. From a clinical point of view, the necessity of supplying i.v.
glucose to these inf'ants has to be questioned.
The relationship between GPRs and ketone body concentrations in the infants
of diabetic mothers we find, illustrate that, when maternal diabetes is strictly
regulated, metabolism in their newborn infants is adequately integrated. With

































find higher concentrations of ketone bodies. Since Bougndres et al. (3) found that
ketone body concentrations in newborn infants are correlated with ketone body
production, it is suggested, that at lower GPR ketone body production is higher.
Dcspite the fact that maternal diabetes was tightly controllcd, there was a
relationship between the mean third trimester blood glucose value of the mothers and
the standard deviation score of birth weight. This indicates that hypothesis, also holds
in diabetic mother-infant pairs where the diabetes is regulated to almost normal blood
glucose levels. If the relationship between mean third trimester blood glucose values
and SDS of birthweight is only present in pregnancies of diabetic women, needs to be
investigated in pregnancies of non-diabetic women.
The brain is the major glucose consuming organ. In appropriately sized
newborn infants, brain weight is approximately 12 Vo of body weight (a). In case of
intra-uterine growth retardation, there is a reduction in brain weight, however the
relative brain size (brain weight as percentage of body weight) is increased. Moreover,
the liver weight is decreased more than the brain weight (5). Thus weight of the
glucose producing organ is decreased more than the weight of the most important
glucose consuming organ. There are no data on the amount of glucose consumed by
the perinatal brain. Our data of glucose turnover, were obtained during steady state,
indicating that the glucose disappearance rate equals the glucose appearance rate.
Thus brain glucose consumption during these studies can not have exceeded the
glucose disappearance rate. When the total glucose disappearance was related to the
brain weight, and expressed in mg/ 100 g brain tissue per minute, a value is obtained,
which we have called brain glucose availability (chapter 6). Brain glucose availabiliry
ranged liom 1.85 to 7,02 mg/ 100 g brain tissue per minute. This brain glucose
availability was inversely related to the relative brain size. In the infants with the
highest relative brain size (up to 20 Vo), the lowest brain glucose availability was
found. From this study we conclude that especially the SGA infants have a very low
glucose availability, suggesting that intra-uterine growth retardation does not only
afTect glucose production rate, but also influences, or regulates, cerebral metabolism.
This is emphasized by the fact that despite the low glucose availability, and thus low
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glucose consumption, none of the infants exhibited any neurological symptoms which
could be attributed to lack of substrate for the brain. More research, possibly with use
of PET scanning, is needed to unravel how the perinatal brain adapts to this low
metabolic supply.
Lactate is considered to be an important compound in the intermediate
metabolism. Unlike glucose, which is produced only in the liver, lactate is produced in
many organs and tissues in the body, e.g. erythrocytes and muscle, and oxidized by
few organs, e.g. heart (and brain ?). Most of the lactate produced, is recycled to
glucose in the liver (Cori-cycle). An attempt has been made to measure lactate
turnover as described in chapter 7. In this study we found a lactate appearance rate of
3.2 mg/kg.min. By analysis of the expired gas we found that 84 o/o of the lactate which
disappears fron the pool, was oxidized. Thus it seems, that recycling of lactate back
to glucose in this infant was not a major pathway of lactate. Lactate kinetics are
difficult to quanti$r, lactate is produced at many sites, and rapidly exchanges the label
with pyruvate. Also the sampling and intusion sites are important, the most reliable
mode to study lactate turnover probably is with infusing the tracer in the left ventricle,
and sampling for enrichment of lactate in the right ventricle (6). It is clear that such
studies are not feasible in newborn infants.
It is important to monitor blood glucose concentration in infants at risk for
derangements in glucosc homeostasis. The most reliable technique for blood glucose
measurement, is with a glucose analyzer, based on the hexokinase or on the glucose
oxidase method. Such equipment is not available at the bedside however, and
therefore glucose teststrips are used. The reliability of such teststrips has oftcn been
questioned. Their performance mostly is evaluated with regression analysis. For adult
subjects with diabetes another technique has been proposed, the error grid analysis
(7), because of the limitations of regression analysis to evaluate glucose teststrips. In
chapter 8, we propose an error grid analysis for newborn infants. This neonatal error
grid analysis is a method, which gives insight into the clinical value of the
performance of a teststrip in newborn infants. In this analysis the glucose teststrip




























laboratory techniques. As is clearly shown in chapter 8, regression analysis is
unsuitable to evaluate the performance of glucose teststrips in newborn infants, much
more information is obtained with the neonatal error grid analysis. The evaluation of
two teststrips in the neonatal intensive care, showed complete different performances
of these teststrips. The zones in the grid indicate the implications of a teststrip value
on medical decision making based on the teststrip value.
Recently a device has been developed to measure glucose with a probe
transcutaneously (7). Measurements in newborn infants show that in each infant there
is a good correlation between the glucose concentration in the dialysate and the blood
glucose concentration, however there is a large interindividual variation between the
concentration in the dialysate. As is outlined in chapter 7 this is probably due to a
relation between skin-permeability and birth weight. Therefore, the subcutaneous
measurement of glucose, either by microdialysis, or directly by a glucose sensor, offers
more perspective for monitoring of blood glucose in the future. It remains to be
explored how the microdialysis technique , subcutaneous and transcutaneous, can be
used for tracer studies.
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